Eton Pharmaceuticals (ETON) Interest & Investment Income (2018 - 2026)
Eton Pharmaceuticals' (ETON) quarterly Interest & Investment Income came in at -$1.1 million in Q2 2026, down 3.07% year-over-year from -$1.1 million in Q2 2025, and down 81.76% quarter-over-quarter from -$592000.0 in Q3 2025.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Interest & Investment Income (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has disclosed Interest & Investment Income across 6 years of filings, most recently posting -$1.1 million for Q2 2026.
- In Q2 2026, Interest & Investment Income fell 3.07% year-over-year to -$1.1 million; the TTM figure through Jun 2026 stood at -$3.7 million (down 75.42% YoY), while the FY2018 annual figure was $164000.0, up 368.57% from the prior year.
- Interest & Investment Income came in at -$1.1 million for Q2 2026 at Eton Pharmaceuticals, down from -$592000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$8000.0 in Q3 2024 to a low of -$1.1 million in Q2 2026.
- Average Interest & Investment Income over 4 years is -$409200.0, with a median of -$125000.0 recorded in 2023.
- Year-over-year, Interest & Investment Income soared 91.27% in 2024 and plunged 9245.45% in 2025.
- Over 4 years, Interest & Investment Income stood at -$31000.0 in 2023, then surged by 74.19% to -$8000.0 in 2024, then sank by 7300.0% to -$592000.0 in 2025, then slumped by 81.76% to -$1.1 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$1.1 million in Q2 2026, -$592000.0 in Q3 2025, and -$1.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | -1.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.08 Mn |
| Sep 30, 2025 | -592,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | -124,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Sep 30, 2019 | 77,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 144,000.00 |
| Dec 31, 2018 | 82,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 28,000.00 |
| Mar 31, 2018 | 29,000.00 |